Pharmacovigilance 2e
Book 1
Book 2
Book 3
Book 1
Book 2
Book 3
Book 1
Book 2
Book 3
Book 1
Book 2
Book 3
Home > Medicine & Health Science textbooks > Medical specialties, branches of medicine > Pharmacology > Pharmacovigilance 2e
Pharmacovigilance 2e

Pharmacovigilance 2e


     0     
5
4
3
2
1



Out of Stock


Notify me when this book is in stock
X
About the Book

Written by an international team of outstanding editors and contributors, Pharmacovigilance, 2nd Edition is the definitive text on this important subject. The new edition has been completely revised and updated to include the latest theoretical and practical aspects of pharmacovigilance including legal issues, drug regulatory requirements, methods of signal generation, reporting schemes and pharmacovigilance in selected system-organ classes. . * The editors and contributors are of excellent standing within the pharmacovigilance community* The text provides exemplary coverage of all the relevant issues* The definitive book on the subject

Table of Contents:
Contributors. Preface. Foreword. PART I. THE BASIS OF PHARMACOVIGILANCE. 1. Introduction (Ronald D. Mann and Elizabeth B. Andrews). 2. Legal Basis - EU (Nicholas Macfarlane, Paul Brown, Caroline Moore, Claire Taylor, Uwe Froehlich, Tanja Barton, Olivier Banchereau and Paola La Licata). 3. Legal Basis - United States (Jayne P. Bultena). 4. Ethical Oversight, Consent and Confidentiality (Donna A. Boswell and Elizabeth B. Andrews). 5. Pharmacovigilance-Related Topics at the Level of the International Conference on Harmonisation (Priya Bahri and Panos Tsintis). 6. Periodic Safety Update Reports (Patrice Verpillat and Mondher Toumi). 7. Non-Clinical Safety Evaluation and Adverse Events in Phase I Trials (Patricia M. Reed, Stuart J. Mair and Stephen Freestone). 8. Mechanisms of Adverse Drug Reactions (Munir Pirmohamed and B. Kevin Park). 9. Micturin and Torsades de Pointes (Richard N. Wild). 10. Withdrawal of Terodiline: A Tale of Two Toxicities (Rashmi R. Shah). 11. Nomifensine and Haemolytic Anaemia (Peter D. Stonier and J. Guy Edwards). PART II. SIGNAL GENERATION. 12. WHO Programme - Global Monitoring (I. Ralph Edwards and Cecilia Biriell). 13. Medical Dictionary for Regulatory Activities (MedDRA(r)) (Elliot Brown). 14. Regulatory Pharmacovigilance in the EU (Priya Bahri, Panos Tsintis and Patrick C. Waller). 15. Spontaneous Reporting - UK (Sarah Davis, Bridget King and June M. Raine). 16. Spontaneous Reporting - France (Nicholas Moore, Carmen Kreft-Jais and Alban Dhanani). 17. Spontaneous Reporting in Germany (Ulrich Hagemann and Norbert Paeschke). 18. Spontaneous Reporting - United States (David J. Graham, Syed R. Ahmad and Toni Piazza-Hepp). 19. Statistical Methods of Signal Detection (Stephen Evans). 20. Statistical Methods of Evaluating Pharmacovigilance Data (Bernard Begaud). 21. Data Mining in Pharmacovigilance: A View from the Uppsala Monitoring Centre (I. Ralph Edwards, Marie Lindquist, Andrew Bate and G. Niklas Noren). 22. Pharmacovigilance in the Netherlands (Kees van Grootheest and Eugene van Puijenbroek). 23. CIOMS Working Groups and their Contribution to Pharmacovigilance (Sue Roden and Trevor Gibbs). 24. PEM in the UK (Saad A.W. Shakir). 25. PEM in New Zealand (Mira Harrison-Woolrych and David M. Coulter). 26. MEMO in the United Kingdom (Douglas Steinke, Josie M.M. Evans and Thomas M. Macdonald). 27. The General Practice Research Database: Now and the Future (John Parkinson, Sarah Davis and Tjeerd Van Staa). 28. Overview of North American Databases (Brian L. Strom and Judith L. Kinman). 29. Other Databases in Europe for the Analytic Evaluation of Drug Effects (Miriam C.J.M. Sturkenboom). 30. Surveillance for Medical Devices - USA (Thomas P. Gross). 31. Pharmacovigilance and Risk Management in Japan (Kiyoshi Kubota and Hiroko Koyama). PART III. PHARMACOVIGILANCE AND SELECTED SYSTEM ORGAN CLASSES. 32. Dermatological ADRs (Laurence Allanore-Valeyrie and Jean-Claude Roujeau). 33. Gastrointestinal ADRs (John R. Wood and Graham A. Pipkin). 34. Haematological ADRs (Peter J. Carey). 35. Hepatic ADRs (Guruprasad P. Aithal and Christopher P. Day). 36. Ocular Side Effects of Prescription Medications (F.W. Fraunfelder). 37. Drug Safety in Pregnancy (Christina D. Chambers and Elizabeth B. Andrews). 38. Renal Adverse Drug Reactions (Gert A. Verpooten). 39. Anaesthetic Adverse Drug Reactions (Anita Holdcroft). 40. Pharmacovigilance in Pediatrics (Solomon Iyasu and M. Dianne Murphy). 41. The Cardiovascular Spectrum of Adverse Drug Reactions (Judith Hsia, Jinping Mo, Laura Burleson and Annlouise R. Assaf). 42. Drugs and the Elderly (Una Martin and Jamie J. Coleman). PART IV. KEY CURRENT TOPICS. 43. US Activities in Risk Management of Pharmaceutical Products (Jonca Bull). 44. Risk Management - a European Regulatory View (June M. Raine). 45. The Efficacy and Safety of Selective Serotonin Reuptake Inhibitors for the Treatment of Depression in Children and Adolescents (Julie Magno Zito and Daniel J. Safer). 46. Pharmacoepidemiology of Hormone Therapy: An Evolving Picture (Annlouise R. Assaf, Laura E. Burleson and Joann E. Manson). 47. NSAIDs - COX-2 Inhibitors - Risks and Benefits (K. Arnold Chan and S. Christopher Jones). 48. Introduction to Pharmionics: The Vagaries in Ambulatory Patients' Adherence to Prescribed Drug Dosing Regimens, and Some of Their Clinical and Economic Consequences (John Urquhart and Bernard Vrijens). PART V. LESSONS AND DIRECTIONS. 49. Teaching and Learning Pharmacovigilance (Frank May). 49b. Practical Experience in Teaching Pharmacovigilance (Stephen Evans). 50. Fatal Medication Errors and Adverse Drug Reactions - Coroners' Inquests and Other Sources (R.E. Ferner, S.E. McDowell and A.K. Cotter). 51. Pharmacogenetics and the Genetic Basis of ADRs (Penelope K. Manasco). 52. Keynote Clinical Lessons from Pharmacovigilance (David H. Lawson and Keith Beard). Index.

About the Author :
Ronald D. Mann, Professor Emeritus, University of Southampton, UK. Elizabeth B. Andrews, RTI Health Solutions, Research Triangle Institute, UNC School of Public Health and School of Pharmacy, NC, USA

Review :
"Pharmacovigilance is an excellent and detailed examination of the current state of both science and practice." (The Pharmaceutical Journal, November 2007)


Best Sellers


Product Details
  • ISBN-13: 9780470059210
  • Publisher: John Wiley and Sons Ltd
  • Publisher Imprint: Wiley-Blackwell
  • Height: 249 mm
  • No of Pages: 702
  • Weight: 1672 gr
  • ISBN-10: 0470059214
  • Publisher Date: 07 Feb 2007
  • Binding: Other digital
  • Language: English
  • Spine Width: 45 mm
  • Width: 197 mm


Similar Products

Add Photo
Add Photo

Customer Reviews

REVIEWS      0     
Click Here To Be The First to Review this Product
Pharmacovigilance 2e
John Wiley and Sons Ltd -
Pharmacovigilance 2e
Writing guidlines
We want to publish your review, so please:
  • keep your review on the product. Review's that defame author's character will be rejected.
  • Keep your review focused on the product.
  • Avoid writing about customer service. contact us instead if you have issue requiring immediate attention.
  • Refrain from mentioning competitors or the specific price you paid for the product.
  • Do not include any personally identifiable information, such as full names.

Pharmacovigilance 2e

Required fields are marked with *

Review Title*
Review
    Add Photo Add up to 6 photos
    Would you recommend this product to a friend?
    Tag this Book Read more
    Does your review contain spoilers?
    What type of reader best describes you?
    I agree to the terms & conditions
    You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.

    CUSTOMER RATINGS AND REVIEWS AND QUESTIONS AND ANSWERS TERMS OF USE

    These Terms of Use govern your conduct associated with the Customer Ratings and Reviews and/or Questions and Answers service offered by Bookswagon (the "CRR Service").


    By submitting any content to Bookswagon, you guarantee that:
    • You are the sole author and owner of the intellectual property rights in the content;
    • All "moral rights" that you may have in such content have been voluntarily waived by you;
    • All content that you post is accurate;
    • You are at least 13 years old;
    • Use of the content you supply does not violate these Terms of Use and will not cause injury to any person or entity.
    You further agree that you may not submit any content:
    • That is known by you to be false, inaccurate or misleading;
    • That infringes any third party's copyright, patent, trademark, trade secret or other proprietary rights or rights of publicity or privacy;
    • That violates any law, statute, ordinance or regulation (including, but not limited to, those governing, consumer protection, unfair competition, anti-discrimination or false advertising);
    • That is, or may reasonably be considered to be, defamatory, libelous, hateful, racially or religiously biased or offensive, unlawfully threatening or unlawfully harassing to any individual, partnership or corporation;
    • For which you were compensated or granted any consideration by any unapproved third party;
    • That includes any information that references other websites, addresses, email addresses, contact information or phone numbers;
    • That contains any computer viruses, worms or other potentially damaging computer programs or files.
    You agree to indemnify and hold Bookswagon (and its officers, directors, agents, subsidiaries, joint ventures, employees and third-party service providers, including but not limited to Bazaarvoice, Inc.), harmless from all claims, demands, and damages (actual and consequential) of every kind and nature, known and unknown including reasonable attorneys' fees, arising out of a breach of your representations and warranties set forth above, or your violation of any law or the rights of a third party.


    For any content that you submit, you grant Bookswagon a perpetual, irrevocable, royalty-free, transferable right and license to use, copy, modify, delete in its entirety, adapt, publish, translate, create derivative works from and/or sell, transfer, and/or distribute such content and/or incorporate such content into any form, medium or technology throughout the world without compensation to you. Additionally,  Bookswagon may transfer or share any personal information that you submit with its third-party service providers, including but not limited to Bazaarvoice, Inc. in accordance with  Privacy Policy


    All content that you submit may be used at Bookswagon's sole discretion. Bookswagon reserves the right to change, condense, withhold publication, remove or delete any content on Bookswagon's website that Bookswagon deems, in its sole discretion, to violate the content guidelines or any other provision of these Terms of Use.  Bookswagon does not guarantee that you will have any recourse through Bookswagon to edit or delete any content you have submitted. Ratings and written comments are generally posted within two to four business days. However, Bookswagon reserves the right to remove or to refuse to post any submission to the extent authorized by law. You acknowledge that you, not Bookswagon, are responsible for the contents of your submission. None of the content that you submit shall be subject to any obligation of confidence on the part of Bookswagon, its agents, subsidiaries, affiliates, partners or third party service providers (including but not limited to Bazaarvoice, Inc.)and their respective directors, officers and employees.

    Accept

    Fresh on the Shelf


    Inspired by your browsing history


    Your review has been submitted!

    You've already reviewed this product!